A. Jamal

A Multicenter Randomized Clinical Trial of Hemodialysis Access Blood Flow Surveillance Compared to Standard of Care: The Hemodialysis Access Surveillance Evaluation (HASE) Study

L. Salman, A. Asif, A. Rizvi, 2020, Kidney international reports.

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

A. Villaflor, M. Pfeffer, C. Held, 2021, European heart journal.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.

A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.

F. Menzaghi, S. Fishbane, C. Munera, 2019, The New England journal of medicine.

Serum Sickness-Like Illness Associated with N-Acetyicysteine Therapy

A. Jamal, S. Mohammed, L. Robison, 1994, The Annals of pharmacotherapy.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Debra F. Weinstein, Michael G. Miller, M. A. Ferreira, 2019, Lancet.